Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with

Nikos Werner1, Sven Wassmann, Patrick Ahlers

  • 1Klinik für Innere Medizin II, Universitätsklinikum Bonn, Bonn, Germany. georg.nickenig@ukb.uni-bonn.de

Insights

Endothelial cell apoptosis, measured by circulating microparticles, predicts endothelial dysfunction in coronary artery disease patients. This finding offers new avenues for cardiovascular risk assessment and treatment strategies.

Area of Science:

  • Cardiovascular Medicine
  • Cell Biology
  • Biomarkers

Background:

  • Endothelial dysfunction is a key predictor of cardiovascular morbidity and mortality.
  • Endothelial cell apoptosis is a potential contributing factor to endothelial dysfunction.

Purpose of the Study:

  • To investigate the relationship between endothelial cell apoptosis and endothelial function in humans with coronary artery disease (CAD).
  • To determine if circulating apoptotic microparticles can predict endothelial dysfunction.

Main Methods:

  • Invasive assessment of endothelial-dependent vasodilation using quantitative coronary angiography during acetylcholine infusion in 50 CAD patients.
  • Quantification of circulating CD31+/annexin V+ apoptotic microparticles via flow cytometry in peripheral blood.

Main Results:

  • Increased counts of apoptotic microparticles positively correlated with impaired coronary endothelial function.
  • Multivariate analysis confirmed that elevated apoptotic microparticle counts predict severe endothelial dysfunction, independent of traditional cardiovascular risk factors.

Conclusions:

  • Endothelial-dependent vasodilation in CAD patients is significantly influenced by the degree of endothelial cell apoptosis.
  • Circulating CD31+/annexin V+ apoptotic microparticles serve as a measurable indicator of endothelial apoptosis.
  • These findings may enhance cardiovascular risk assessment and inform future therapeutic strategies for CAD.
Abstract

Related Concept Videos